Peginterferon alfa-2a biosimilar (Nanogen)
聚乙二醇化干扰素α2a生物类似药 (Nanogen)
Report date: 2022/01/14 13:23:58
Base Information
Drug NamePeginterferon alfa-2a biosimilar (Nanogen)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNanogen Biopharmaceutical Co
China Registration ClassN/A
Develop Information
Active CompaniesNanogen Biopharmaceutical Co
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A